Endologix LLC
(Other OTC/NBB : ELGX)

( )
ELGX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 1.36%636.111.0%$881.44m
DHRDanaher Corp. -0.99%312.940.7%$867.89m
ABTAbbott Laboratories 1.48%130.280.8%$679.33m
MDTMedtronic Plc -0.36%106.890.6%$665.91m
ISRGIntuitive Surgical, Inc. -1.74%321.630.8%$468.26m
BDXBecton, Dickinson & Co. 0.92%244.161.0%$387.41m
DXCMDexCom, Inc. -7.27%519.497.8%$368.29m
BSXBoston Scientific Corp. -0.35%39.461.0%$353.24m
SYKStryker Corp. -0.23%246.841.3%$345.59m
ALGNAlign Technology, Inc. -0.83%619.756.4%$308.13m
EWEdwards Lifesciences Corp. -1.20%108.500.4%$264.44m
AAgilent Technologies, Inc. -1.14%149.271.6%$246.00m
ZBHZimmer Biomet Holdings, Inc. -1.42%121.181.7%$234.63m
IDXXIDEXX Laboratories, Inc. -2.08%586.543.8%$213.19m
WSTWest Pharmaceutical Services, Inc. -0.75%434.111.6%$181.85m

Company Profile

Endologix develops and manufactures minimally invasive treatments for aortic disorders. Endologix's flagship product is the Powerlink(R) System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S.